| Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis J Li, B Zou, YH Yeo, Y Feng, X Xie, DH Lee, H Fujii, Y Wu, LY Kam, F Ji, ... The lancet Gastroenterology & hepatology 4 (5), 389-398, 2019 | 994 | 2019 |
| Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis X Tantai, Y Liu, YH Yeo, M Praktiknjo, E Mauro, Y Hamaguchi, ... Journal of hepatology 76 (3), 588-599, 2022 | 291 | 2022 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 221 | 2022 |
| Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis CH Tseng, YC Hsu, TH Chen, F Ji, IS Chen, YN Tsai, H Hai, T Hosaka, ... The Lancet Gastroenterology & Hepatology 5 (12), 1039-1052, 2020 | 109 | 2020 |
| Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: a systematic review and meta-analysis F Ji, YH Yeo, MT Wei, E Ogawa, M Enomoto, DH Lee, E Iio, J Lubel, ... Journal of hepatology 71 (3), 473-485, 2019 | 96 | 2019 |
| Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis L Rongrui, H Na, L Zongfang, J Fanpu, J Shiwen Current pharmaceutical design 20 (11), 1715-1725, 2014 | 90 | 2014 |
| Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation S Su, WCW Wong, Z Zou, DD Cheng, JJ Ong, P Chan, F Ji, MF Yuen, ... The Lancet Global Health 10 (2), e278-e287, 2022 | 89 | 2022 |
| Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States X Gao, F Lv, X He, Y Zhao, Y Liu, J Zu, L Henry, J Wang, YH Yeo, F Ji, ... Journal of Hepatology 78 (1), 16-27, 2023 | 72 | 2023 |
| Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data-and model-driven study J Zu, ML Li, ZF Li, MW Shen, YN Xiao, FP Ji Infectious diseases of poverty 9 (04), 21-34, 2020 | 69 | 2020 |
| Tenofovir alafenamide to prevent perinatal hepatitis B transmission: a multicenter, prospective, observational study QL Zeng, ZJ Yu, F Ji, GM Li, GF Zhang, JH Xu, ZM Chen, GL Cui, W Li, ... Clinical Infectious Diseases 73 (9), e3324-e3332, 2021 | 68 | 2021 |
| Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical … F Ji, B Wei, YH Yeo, E Ogawa, B Zou, CD Stave, Z Li, S Dang, N Furusyo, ... Alimentary pharmacology & therapeutics 47 (5), 550-562, 2018 | 66 | 2018 |
| Evaluation of trends in alcohol use disorder–related mortality in the US before and during the COVID-19 pandemic YH Yeo, X He, PS Ting, J Zu, CV Almario, BMR Spiegel, F Ji JAMA Network Open 5 (5), e2210259-e2210259, 2022 | 60 | 2022 |
| Association of direct-acting antiviral therapy with liver and nonliver complications and long-term mortality in patients with chronic hepatitis C E Ogawa, N Chien, L Kam, YH Yeo, F Ji, DQ Huang, R Cheung, ... JAMA Internal Medicine 183 (2), 97-105, 2023 | 56 | 2023 |
| Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019 F Ji, L Li, Z Li, Y Jin, W Liu Stem cells translational medicine 9 (7), 813-814, 2020 | 40 | 2020 |
| Excess risk for acute myocardial infarction mortality during the COVID‐19 pandemic YH Yeo, M Wang, X He, F Lv, Y Zhang, J Zu, M Li, Y Jiao, JE Ebinger, ... Journal of medical virology 95 (1), e28187, 2023 | 39 | 2023 |
| Isothermal nucleic acid amplification technology for rapid detection of virus Z Wei, X Wang, H Feng, F Ji, D Bai, X Dong, W Huang Critical Reviews in Biotechnology 43 (3), 415-432, 2023 | 36 | 2023 |
| Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States F Lv, X Gao, AH Huang, J Zu, X He, X Sun, J Liu, N Gao, Y Jiao, ... EClinicalMedicine 54, 2022 | 36 | 2022 |
| A general-purpose nanohybrid fabricated by polymeric Au (I)-peptide precursor to wake the function of peptide therapeutics J Yan, F Ji, S Yan, W You, F Ma, F Li, Y Huang, W Liu, W He Theranostics 10 (19), 8513, 2020 | 35 | 2020 |
| Seasonality of cellulitis: evidence from Google Trends X Zhang, S Dang, F Ji, J Shi, Y Li, M Li, X Jia, Y Wan, X Bao, W Wang Infection and drug resistance, 689-693, 2018 | 35 | 2018 |
| Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line … ZC Jin, JJ Chen, XL Zhu, XH Duan, YJ Xin, BY Zhong, JZ Chen, J Tie, ... EClinicalMedicine 72, 2024 | 34 | 2024 |